Ticker >

HPC Biosciences share price

HPC Biosciences Ltd.

BSE: 535217 SECTOR: Agriculture  4563   7   0

25.68
-0.52 (-1.98%)
BSE: 29 Jul 4:00 PM

Price Summary

Today's High

₹ 25.68

Today's Low

₹ 25.68

52 Week High

₹ 25.68

52 Week Low

₹ 25.68

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

409.85 Cr.

Enterprise Value

409.55 Cr.

No. of Shares

15.96 Cr.

P/E

19753.85

P/B

12.48

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  2.06

CASH

0.3 Cr.

DEBT

0 Cr.

Promoter Holding

21.93 %

EPS (TTM)

₹  0

Sales Growth

90.55%

ROE

3.62 %

ROCE

3.69%

Profit Growth

247.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year90.55%
3 Year5.53%
5 Year4.12%

Profit Growth

1 Year247.42%
3 Year81.1%
5 Year20.49%

ROE%

1 Year3.62%
3 Year2.16%
5 Year1.76%

ROCE %

1 Year3.69%
3 Year2.23%
5 Year1.87%

Debt/Equity

0

Price to Cash Flow

301.36

Interest Cover Ratio

2897.0781

CFO/PAT (5 Yr. Avg.)

1.63814451971441

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2023 21.93 0.00
Jun 2023 21.93 0.00
Mar 2023 21.93 0.00
Dec 2022 21.93 0.00
Sep 2022 21.93 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 2897.0781.
  • The Company has been maintaining an effective average operating margins of 65.56168% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 92.9928.
  • The company has a good cash flow management; CFO/PAT stands at 1.63814451971441.

 Limitations

  • The company has shown a poor revenue growth of 5.53241224020706% for the Past 3 years.
  • Company has a poor ROE of 2.15916666666667% over the past 3 years.
  • Company has a poor ROCE of 2.23256666666667% over the past 3 years
  • Company has high debtor days of 888.0973.
  • The company is trading at a high EV/EBITDA of 771.2877.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 2.26 1.94 1.6 1.2 2.29
Total Expenditure 0.88 1 0.39 0.33 0.67
Operating Profit 1.37 0.94 1.21 0.87 1.62
Other Income 0.19 0.14 0.09 0.1 0.09
Interest 0 0.01 0 0 0
Depreciation 0.99 0.84 0.72 0.61 0.51
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.57 0.23 0.58 0.36 1.19
Tax 0.06 0.03 0.02 0.02 0.02
Net Profit 0.51 0.2 0.55 0.34 1.17
Adjusted EPS (Rs.) 0.03 0.01 0.03 0.02 0.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 15.96 15.96 15.96 15.96 15.96
Total Reserves 14.63 14.83 15.38 15.72 16.89
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.4 0.47 0.56 0.46 0.28
Total Liabilities 31 31.26 31.9 32.14 33.13
Assets
Net Block 5.75 4.91 4.19 3.58 3.07
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.3 0.3 0.3 0.3 0.3
Loans & Advances 3.69 3.69 3.69 3.69 3.69
Other N/C Assets 0.09 0.02 0 0 0
Current Assets 21.17 22.34 23.72 24.57 26.07
Total Assets 31 31.26 31.9 32.14 33.13
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 0.57 0.23 0.58 0.36 1.19
Adjustment 0.92 0.77 0.64 0.51 0.43
Changes in Assets & Liabilities -0.38 -0.82 -0.05 -0.04 -0.26
Tax Paid -0.02 -0.1 0 0 0
Operating Cash Flow 1.09 0.08 1.17 0.82 1.36
Investing Cash Flow -1.87 -0.1 -0.96 -0.79 0.06
Financing Cash Flow 0 0 0 0 0
Net Cash Flow -0.77 -0.02 0.21 0.03 1.42

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Dec 2022% Mar 2023% Jun 2023% Sep 2023%
promoters 21.93 21.93 21.93 21.93 21.93
madhu anand 21.87 21.87 21.87 21.87 21.87
tarun chauhan 0.06 0.06 0.06 0.06 0.06
PARTICULARS Sep 2022% Dec 2022% Mar 2023% Jun 2023% Sep 2023%
investors 78.07 78.07 78.07 78.07 78.07
antaryami traders private... 1.10 1.10 1.10 1.10 1.10
ashvin verma 1.06 1.06 1.06 1.06 1.06
globe capital market limi... 1.15 1.15 1.15 1.15 1.15
jai kishan 2.78 2.78 2.78 2.78 2.78
ladoo garments private li... 2.10 2.10 2.10 2.10 2.10
lunar builders pvt ltd 3.33 3.33 3.33 3.33 3.33
mahashiv metal and alloys... 2.03 2.03 2.03 2.03 2.03
murlidhargiridhar trading... 2.83 2.83 2.83 2.83 2.83
rekha rathi 1.57 1.57 1.57 1.57 1.57
river high right share br... 3.23 3.23 3.23 3.23 3.23
truckling vinmay trading ... 4.16 4.16 4.16 4.16 4.16
unite buildcreate private... 1.01 1.01 1.01 1.01 1.01
vishnudham marketing priv... 2.18 2.18 2.18 2.18 2.18
deepak rathi huf 1.57 1.57 1.57 - -
dhananjay rathi huf 1.57 1.57 1.57 - -
kshitij rathi huf 1.57 1.57 1.57 - -
richi khemka 5.37 5.37 5.37 - -
rupesh jha 4.52 4.52 4.52 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

HPC Biosciences Stock Price Analysis and Quick Research Report. Is HPC Biosciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

HPC Biosciences stock price today is Rs 25.68. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse HPC Biosciences . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). HPC Biosciences has a PE ratio of 19753.8461538462 which is high and comparatively overvalued .

  • Share Price: - The current share price of HPC Biosciences is Rs 25.68. One can use valuation calculators of ticker to know if HPC Biosciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. HPC Biosciences has ROA of 3.5838 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. HPC Biosciences has a Current ratio of 92.9928 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. HPC Biosciences has a ROE of 3.6247 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. HPC Biosciences has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - HPC Biosciences has reported revenue growth of 90.5529 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of HPC Biosciences for the current financial year is 70.8294276148832 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for HPC Biosciences is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of HPC Biosciences is Rs 0.0013 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of HPC Biosciences in Ticker for free. Also, one can get the intrinsic value of HPC Biosciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about HPC Biosciences
X